PMID- 12438273 OWN - NLM STAT- MEDLINE DCOM- 20021217 LR - 20071114 IS - 0008-5472 (Print) IS - 0008-5472 (Linking) VI - 62 IP - 22 DP - 2002 Nov 15 TI - Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis. PG - 6724-30 AB - Cutaneous malignant melanoma (CMM), already known for its highly aggressive behavior and resistance to conventional therapy, has evolved into a health crisis by virtue of a dramatic elevation in incidence. The underlying genetic basis for CMM, as well as the fundamental role for UV radiation in its etiology, is now widely accepted. However, the only bona fide genetic locus to emerge from extensive analysis of CMM suppressor candidates is INK4a/ARF at 9p21, which is lost frequently in familial and occasionally in somatic CMM. The functional relationship between INK4a/ARF and UV radiation in the pathogenesis of CMM is largely unknown. Recently, we reported that hepatocyte growth factor/scatter factor (HGF/SF)-transgenic mice develop melanomas after a single erythemal dose of neonatal UV radiation, supporting epidemiological data implicating childhood sunburn in CMM. Here we show that neonatal UV irradiation induces a full spectrum of melanocyte pathology from early premalignant lesions through distant metastases. Cutaneous melanomas arise with histopathological and molecular pathogenetic features remarkably similar to CMM, including loss of ink4a/arf. A role for ink4a/arf in UV-induced melanomagenesis was directly assessed by placing the HGF/SF transgene on a genetic background devoid of ink4a/arf. Median time to melanoma development induced by UV radiation was only 50 days in HGF/SF ink4a/arf(-/-) mice, compared with 152 and 238 days in HGF/SF ink4a/arf(+/-) and HGF/SF ink4a/arf(+/+) mice, respectively. These studies provide experimental evidence that ink4a/arf plays a critical role in UV-induced melanomagenesis and strongly suggest that sunburn is a highly significant risk factor, particularly in families harboring germ-line mutations in INK4a/ARF. FAU - Recio, Juan A AU - Recio JA AD - Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892-4264, USA. FAU - Noonan, Frances P AU - Noonan FP FAU - Takayama, Hisashi AU - Takayama H FAU - Anver, Miriam R AU - Anver MR FAU - Duray, Paul AU - Duray P FAU - Rush, Walter L AU - Rush WL FAU - Lindner, Gerd AU - Lindner G FAU - De Fabo, Edward C AU - De Fabo EC FAU - DePinho, Ronald A AU - DePinho RA FAU - Merlino, Glenn AU - Merlino G LA - eng GR - CA-92258/CA/NCI NIH HHS/United States GR - N0I-CO-56000/CO/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Cancer Res JT - Cancer research JID - 2984705R RN - 0 (Cyclin-Dependent Kinase Inhibitor p16) RN - 67256-21-7 (Hepatocyte Growth Factor) SB - IM MH - Animals MH - *Cocarcinogenesis MH - Cyclin-Dependent Kinase Inhibitor p16/*deficiency/genetics MH - Disease Models, Animal MH - Hepatocyte Growth Factor/genetics MH - Humans MH - Melanoma, Experimental/*etiology/genetics MH - Mice MH - Mice, Inbred C57BL MH - Mice, Transgenic MH - Ultraviolet Rays/*adverse effects EDAT- 2002/11/20 04:00 MHDA- 2002/12/18 04:00 CRDT- 2002/11/20 04:00 PHST- 2002/11/20 04:00 [pubmed] PHST- 2002/12/18 04:00 [medline] PHST- 2002/11/20 04:00 [entrez] PST - ppublish SO - Cancer Res. 2002 Nov 15;62(22):6724-30.